Differential course of HIV-1 infection and APOE polymorphism

Comment

Elizabeth H Corder et al. Proc Natl Acad Sci U S A. 2008.

. 2008 Nov 18;105(46):E87.

doi: 10.1073/pnas.0808164105. Epub 2008 Nov 11.

No abstract available

Conflict of interest statement

The authors declare no conflict of interest.

Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression.
Burt TD, Agan BK, Marconi VC, He W, Kulkarni H, Mold JE, Cavrois M, Huang Y, Mahley RW, Dolan MJ, McCune JM, Ahuja SK. Burt TD, et al. Proc Natl Acad Sci U S A. 2008 Jun 24;105(25):8718-23. doi: 10.1073/pnas.0803526105. Epub 2008 Jun 18. Proc Natl Acad Sci U S A. 2008. PMID: 18562290 Free PMC article.

1. Burt TD, et al. Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE ε4/ε4 genotype accelerates HIV disease progression. Proc Natl Acad Sci USA. 2008;105:8718–8723. - PMC - PubMed
1. Corder EH, et al. Differential course of HIV-1 infection and apolipoprotein E polymorphism. Cent Eur J Med. 2007;2:404–416.
1. Corder EH, et al. HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med. 1998;4:1182–1184. - PubMed